Optometrists in Charleston, WV Accepting Medicare

37 Optometrists found. Showing 1 - 20

A2z Eye Care And Logistics Pllc Optometrist - Corneal and Contact Management Medicare: Not Enrolled in Medicare Practice Location: 1031 Charleston Town Ctr, Charleston, WV 25389 Phone: 571-774-0993

Dr. Abigail Donigian, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 501 Summers St, Charleston, WV 25301 Phone: 304-343-3937    Fax: 304-344-3957

Feltz Optometry Of West Virginia Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 209 Washington St W, Charleston, WV 25302 Phone: 248-528-1981    Fax: 614-416-2105

Dr. Laura Marie Suppa Sammons, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4202 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-925-4761    Fax: 304-925-0310

Dr. Donald Paul Cohen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 924 Quarrier St, Charleston, WV 25301 Phone: 304-343-4357    Fax: 304-343-4360

Dr Stephen L. Gaal & Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1013 Town Center Mall, Charleston, WV 25389 Phone: 304-736-4942    Fax: 304-736-4943

Mr. Mark Jeffery Whittington, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3840 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-342-0660    Fax: 304-344-5483

Dr. Stephen L Gaal, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1013 Town Center Mall, Charleston, WV 25389 Phone: 304-342-2874

Dr. Christopher Alan Stansbury, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 501 Summers St, Charleston, WV 25301 Phone: 304-343-3937    Fax: 304-344-3957

Dr. Lee Bryant, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 200 Quarrier St, Charleston, WV 25301 Phone: 304-346-7747

Dr. Jessi Sampson, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3840 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-342-0660

Mrs. Sandra H Whittington, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3840 Pennsylvania Ave, Whittington & Whittington, Charleston, WV 25302 Phone: 304-342-0660    Fax: 304-344-5483

Mountain State Eye Associates, Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1306 Kanawha Blvd East, Charleston, WV 25301 Phone: 304-353-0304    Fax: 304-353-0218

Andrew Cassis, OD Optometrist Medicare: Medicare Enrolled Practice Location: 301 49th St Se Ste A, Charleston, WV 25304 Phone: 304-925-3937    Fax: 304-925-4336

Drs Whittington & Whittington Ptr Optometrist Medicare: Medicare Enrolled Practice Location: 3840 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-342-0660    Fax: 304-344-5483

Charleston Vision Source Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4202 Maccorkle Ave Se, Charleston, WV 25304 Phone: 304-925-4761

Dr. Lynn Ellen Engle-laneve, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 806 Greenbrier St, Charleston, WV 25311 Phone: 304-342-5900    Fax: 304-342-6257

Dr. Walter Seth Ramsey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 Lee St E, Charleston, WV 25301 Phone: 304-343-3363    Fax: 304-342-3311

Greenbrier Vision Center Inc Optometrist Medicare: Medicare Enrolled Practice Location: 806 Greenbrier St, Charleston, WV 25311 Phone: 304-342-5900    Fax: 304-342-6257

Dr. Jeffery Lee Whittington, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3840 Pennsylvania Ave, Charleston, WV 25302 Phone: 304-342-0660    Fax: 304-344-5483

News Archive

Findings raise prospects for new therapies to protect heart from progressive disease

Some of the most commonly prescribed drugs for the treatment of heart failure are beta-blockers and nitrates, which help to relax blood vessels and decrease the heart's workload. The drugs were thought to produce those effects through distinct molecular pathways, but according to a new study led by scientists at Temple University School of Medicine, both types of drugs may help the failing heart by counteracting the effects of an enzyme known as GRK2.

New drug to treat chronic pain in SCD patients

A University of Minnesota Medical School research team led by Kalpna Gupta, Ph.D., has discovered that cannibinoids offer a novel approach to ease the chronic and acute pain caused by sickle cell disease.Using a mouse model of SCD, Gupta and University of Minnesota colleagues studied the pain mechanisms by observing animals that exhibited both musculoskeletal pain and temperature sensitivity, symptoms similarly experienced by humans with SCD. The team compared two classifications of drugs in their ability to manage pain sensed by the animals, the traditionally prescribed classification of drugs, opioids, with a new therapeutic approach, cannabinoids, a synthetic compound based on marijuana derivatives. Currently, the only approved treatment for management of severe pain in SCD is opioids.

Viewpoints: Angelina Jolie on her decision to have a double mastectomy; Justice Ginsburg's 'blind spot' on abortion

My doctors estimated that I had an 87 percent risk of breast cancer and a 50 percent risk of ovarian cancer, although the risk is different in the case of each woman. Only a fraction of breast cancers result from an inherited gene mutation. Those with a defect in BRCA1 have a 65 percent risk of getting it, on average. Once I knew that this was my reality, I decided to be proactive and to minimize the risk as much I could. I made a decision to have a preventive double mastectomy. I started with the breasts, as my risk of breast cancer is higher than my risk of ovarian cancer, and the surgery is more complex (Angelina Jolie, 5/14).

Aridis' AR-301 granted FDA Fast Track Designation for treatment of pneumonia caused by S. aureus

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration granted Fast Track Designation to AR-301, the Company's fully human anti-Staphylococcal alpha-toxin IgG1 monoclonal antibody (mAb).

Read more Medical News

› Verified 9 days ago

• 1(current)
• 2